YTH N6-methyladenosine RNA binding protein F2 (Ensembl:YTH N(6)-methyladenosine RNA binding protein 2)
RGD ID:
1311321
Description:
Predicted to enable C5-methylcytidine-containing RNA reader activity and N6-methyladenosine-containing RNA reader activity. Predicted to be involved in several processes, including hematopoietic stem cell proliferation; regulation of gene expression; and regulation of stem cell differentiation. Predicted to be located in several cellular components, including centriolar satellite; cytoplasmic ribonucleoprotein granule; and cytosol. Orthologous to human YTHDF2 (YTH N6-methyladenosine RNA binding protein F2); INTERACTS WITH (+)-schisandrin B; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.
LOC313053; YTH domain family 2; YTH domain family protein 2; YTH domain family, member 2; YTH domain-containing family protein 2; YTH N(6)-methyladenosine RNA binding protein 2
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of YTHDF2 mRNA
YTHDF2 protein affects the reaction [FTO protein affects the reaction [APOBEC3B protein affects the reaction [Arsenic results in increased mutagenesis of TP53 gene]]] and YTHDF2 protein affects the reaction [FTO protein affects the reaction [Arsenic results in increased expression of H2AX protein]]
YTHDF2 protein affects the reaction [FTO protein affects the reaction [APOBEC3B protein affects the reaction [Arsenic results in increased mutagenesis of TP53 gene]]] and YTHDF2 protein affects the reaction [FTO protein affects the reaction [Arsenic results in increased expression of H2AX protein]]
[bisphenol A co-treated with Fulvestrant] results in decreased methylation of YTHDF2 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of YTHDF2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of YTHDF2 mRNA
[bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of YTHDF2 gene and [bisphenol A co-treated with Fulvestrant] results in decreased methylation of YTHDF2 gene
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of YTHDF2 mRNA
[MIR145 mRNA results in decreased expression of YTHDF2 protein] which results in increased abundance of N-methyladenosine and YTHDF2 protein inhibits the reaction [MIR145 mRNA results in increased abundance of N-methyladenosine]